The assignment was performed in the similar way as demonstrated for ZM-GP10 and ZM-GP11. Briefly, treatment of CAP-GP10 or CAP-GP11 with Chymotrypsin and DTT, followed by LC-MS analysis of the digestion fragments (9, 10, 11, 12, and 13) confirmed that the Man 5 GlcNAc 2 glycan was attached at the N160 position in CAP-GP10 while this glycan was attached at N173 in CAP-GP11. Biotinylated glycopeptides were immobilized on streptavidin chips and antibody PG9 FAB flowed through as analytes. The surface-plasmon resonance sensorgrams were recorded with 2-fold serial dilutions starting at the highest concentration of 100 M. The respective fitted curves were shown in orange and the kinetic data were shown as inserts. a) ZM-GP2; b) ZM-GP5; c) ZM-GP8; d) CAP-GP2; e) CAP-GP5; f) CAP-GP8. The binding of ZM-GP6 and CAP-GP6 with PG9 Fab was shown in Fig. 5 in the text. The following ZM-and CAP-glycopeptides did not show apparent binding responses at up to 100 M: ZM-GP1, ZM-GP3, ZM-GP4, ZM-GP7, ZM-GP9; CAP-GP1; CAP-GP7, CAP-GP9; and those non-glycosylated peptides. 
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CAP45 gp120 PG9 --116 ± 2 nd ----130 ±5 6.9 ± 0.4 --214 ± 2 nd nd nd PG16 ----nd ------130 ± 2 ----nd nd nd "--", no binding at 100 M; "nd", not determined; *adapted from ref. 13.
